✦ LIBER ✦

416 The oral HDAC inhibitor SB939 shows activity in in vitro and in vivo models of acute myeloid leukemia

✍ Scribed by V. Diermayr; L.C. Ong; Y.K. Loh; A. Cheong; S. Hart; K.C. Goh; H.H. Hentze; H. Wang; K.E. Ethirajulu; J.M. Wood

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor activity of the angiogenesis i

✍ Ulrika Norén-Nyström; Maria Eriksson; Björn Eriksson; Göran Roos; Anders Bergh; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 475 KB

Discovery of a series of imidazopyrazine

✍ Martin J.I. Andrews; J. Andrew Clase; Gregory Bar; Giovanni Tricarico; Paul J. E 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 485 KB

The influence of farnesyl protein transf

✍ Anna Korycka; Piotr Smolewski; Tadeusz Robak 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

Activity of a Specific Inhibitor of the

✍ Druker, Brian J.; Sawyers, Charles L.; Kantarjian, Hagop; Resta, Debra J.; Reese 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 92 KB

5009 ORAL Significant antitumour activit

✍ Hammer, S.; Arnold, N.; Hilpert, F.; Bräutigam, K.; Sommer, A.; Winsel, S.; Klar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB

254 In Vitro and in Vivo Antitumor Activ

✍ Pitts, T.M.; McPhillips, K.L.; Selby, H.M.; Spreafico, A.; Bagby, S.M.; Britt, B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB